{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:31:45Z","timestamp":1789201905085,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"crossref","award":["R01HD044901"],"award-info":[{"award-number":["R01HD044901"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"crossref","award":["P30HD062171"],"award-info":[{"award-number":["P30HD062171"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Investigator Sponsored Trial"},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Human Clinical Core of the Washington University Intellectual and Developmental Disabilities Research Center"},{"DOI":"10.13039\/100000913","name":"James S. McDonnell Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000913","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ymgme.2014.01.012","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T02:15:28Z","timestamp":1391220928000},"page":"445-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria"],"prefix":"10.1016","volume":"111","author":[{"given":"Anna","family":"Hood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy K.","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-4590","authenticated-orcid":false,"given":"Robert","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.01.012_bb0005","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","author":"De Groot","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/humu.20526","article-title":"The PAH gene, phenylketonuria, and a paradigm shift","volume":"28","author":"Scriver","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/87565640701375963","article-title":"Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?","volume":"32","author":"Anderson","year":"2007","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2013.03.020","article-title":"White matter integrity and executive abilities in individuals with phenylketonuria","volume":"109","author":"Antenor-Dorsey","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2013.07.010","article-title":"White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria","volume":"110","author":"White","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0030","first-page":"1","article-title":"Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria","author":"Peng","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","article-title":"Phenylalanine hydroxylase deficiency","volume":"13","author":"Mitchell","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.01.012_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/B:BOLI.0000042985.02049.ff","article-title":"Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review","volume":"27","author":"Brumm","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(94)70360-4","article-title":"Early-treated phenylketonuria: adult neuropsychologic outcome","volume":"124","author":"Ris","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0055","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF03036507","article-title":"Summary of findings from the United States Collaborative Study of children treated for phenylketonuria","volume":"155","author":"Azen","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0060","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/PL00014388","article-title":"Development of intelligence in early treated phenylketonuria","volume":"159","author":"Burgard","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","article-title":"Intelligence and quality of dietary treatment in phenylketonuria","volume":"65","author":"Smith","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","article-title":"Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis","volume":"33","author":"Albrecht","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0080","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ymgme.2009.10.007","article-title":"Executive function in early-treated phenylketonuria: profile and underlying mechanisms","volume":"99","author":"Christ","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0085","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ymgme.2009.10.009","article-title":"Beyond executive function: non-executive cognitive abilities in individuals with PKU","volume":"99","author":"Janzen","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/B:BOLI.0000028781.94251.1f","article-title":"Executive function impairment in early-treated PKU subjects with normal mental development","volume":"27","author":"Leuzzi","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0095","first-page":"60","article-title":"Quality of dietary control in phenylketonuric patients and its relationship with general intelligence","volume":"25","author":"Vilaseca","year":"2010","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0100","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00014222","article-title":"Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria","volume":"155","author":"Burgard","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2008.06.014","article-title":"Stability of blood phenylalanine levels and IQ in children with phenylketonuria","volume":"95","author":"Anastasoaie","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1651-2227.1998.tb01505.x","article-title":"Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria","volume":"87","author":"Arnold","year":"1998","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10545-011-9329-1","article-title":"Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria","volume":"34","author":"Viau","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymgme.2013.09.001","article-title":"Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes","volume":"110","author":"Cleary","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.01.012_bb0125","series-title":"Wechsler Abbreviated Scale of Intelligence","author":"Wechsler","year":"1999"},{"key":"10.1016\/j.ymgme.2014.01.012_bb0130","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ymgme.2014.01.012_bb0135","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"National Institutes of Health Consensus Development Conference Statement: phenylketonuria \u2014 screening and management, October 16\u201318, 2000","volume":"108","author":"N.I. of Health, Consensus Development Panel","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.01.012_bb0140","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc10-0389","article-title":"Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients","volume":"33","author":"Rizzo","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:12:16Z","timestamp":1648156336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1096719214000389"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.01.012","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}